Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.790
https://www.valueinhealthjournal.com/article/S1098-3015(18)33147-4/fulltext
Title :
Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33147-4&doi=10.1016/j.jval.2018.07.790
First page :
Section Title :
Open access? :
No
Section Order :
31